Correspondence 0001213900-25-013349 from OMS Energy Technologies Inc. (OMSE)
OMS Energy Technologies Inc.
Date: Feb. 13, 2025 · CIK: 0002012219 · Accession: 0001213900-25-013349
AI Filing Summary & Sentiment
File numbers found in text: 333-282986
Show Raw Text
CORRESP
1
filename1.htm
OMS Energy Technologies Inc.
10 Gul Circle
Singapore 629566
February 13, 2025
Division of Corporation Finance
Office of Technology
U.S. Securities and Exchange Commission
Washington, DC 20549
Attn: Aliya Ishmukhamedova
Re: OMS
Energy Technologies Inc.
Amendment No. 4 to Registration Statement on Form F-1
Filed January 28, 2025
File No. 333-282986
Dear Sir or Madam,
This letter is in response to your comments on
February 10, 2025 in relation to the Amendment No. 4 to Registration Statement on Form F-1 (the “Registration Statement”)
of OMS Energy Technologies Inc. (the “Company”) filed with the U.S. Securities and Exchange Commission on January 28, 2025.
On the date hereof, the Company has filed an amendment to the Registration Statement. We set forth below in bold the comments in your
letter relating to the Registration Statement followed by our responses to the comments.
Amendment No. 4 to Registration Statement
on Form F-1
Prospectus Summary, page 1
1. We
note your discussion of fluctuations in revenue, gross margin, and net profit between the six months ended September 30, 2024 and September
30, 2023. When highlighting these fluctuations, please prominently disclose there were different basis of accounting in the periods and
that the comparison may not be indicative of your results if both periods were under the same basis of accounting. Revise similar disclosures
made on page 53, 65, and 83, accordingly.
RESPONSE:
We respectfully advise the staff that we have revised our disclosure on page 1 to prominently disclose that financial results for the
six month ended September 20, 2023 and the six months ended September 30, 2024 were prepared under different bases of accounting and that
the comparison between these periods may not be indicative of our financial results and
have added similar disclosures on page 53, 65, and 83, accordingly.
Unaudited Condensed Consolidated Interim
Statements of Changes in Equity, page F-60
2. Please
disclose the details concerning the $5 million capital contribution recorded in the six months ended September 30, 2024. This disclosure
should inform readers as to who, when, and why the contribution was provided. Also, tell us how this capital contribution is reflected
in your statements of cash flows.
RESPONSE: We respectfully advise the staff
that we have revised our disclosure to update the name of line item from “capital contribution” to “conversion of convertible
notes” that is more appropriate and also include a footnote to the $5 million conversion of convertible notes under the unaudited
condensed consolidated interim statements of changes in equity on page F-60, disclosing the relevant details of the capital contribution
with reference to Note 13. We also update the unaudited condensed consolidated interim statements of cash flows to include a supplemental
disclosure of noncash information regarding the conversion of the convertible note for the six months ended September 30, 2024.
During the period from June 16, 2023 through March
31, 2024, the convertible note holders provided the total cash subscription of US$5 million for the convertible notes in advance, which
was reflected as advances from potential investors under the audited consolidated statement of cash flows for the period from June 16,
2023 through March 31, 2024 on page F-8.
Loans and Borrowings, page F-68
3. Please
disclose the facts and circumstances regarding the $5.8 million loan that was paid off and clarify if this is related to the $5 million
capital contribution reported in the Statements of Changes in Equity.
RESPONSE: We respectfully advise the staff
that we have revised the disclosure to the footnote relating to the $5.8 million on page F-68 to provide clarity under the unaudited condensed
consolidated interim financial statements. Please note that this loan is unrelated to the $5 million capital contribution as reported
in the Unaudited Condensed Consolidated Interim Statements of Changes in Equity and such disclaimer was not made on F-68 as prior disclosure
regarding the loan has been made under the Audited Consolidated Financial Statements on F-37 and F-51.
Trade Payables and Other, page F-68
4. We
note “Other payables, non-current” had a balance of $5 million on March 31, 2024, which was subsequently reduced to zero. Please
disclose the details regarding the $5 million and how it was paid off. If it is related to the $5 million capital contribution recorded
in statement of changes in equity, please disclose the relationship.
RESPONSE: We respectfully advise the staff
that we have revised disclosure to the notes relating to the other payables, non-current on page F-68 to detail the nature of the payables
as of March 31, 2024 and its subsequent treatment following the approval and execution of the convertible notes agreements, and thereafter
its conversion into equity on September 30, 2024.
General
5. On page 90 you disclose that for the six months ended September
30, 2024, ARAMCO accounted for 71% of your revenue. Given the significance of this one customer, please disclose this information prominently
in the Prospectus Summary, MD&A, and Business sections
of your filing.
RESPONSE: We respectfully advise the staff
that we have disclosed this information prominently in the Prospectus Summary, MD&A, and Business sections of our filing.
We hope this response has addressed all of the
Staff’s concerns relating to the comment letter. Should you have additional questions regarding the information contained herein,
please contact our securities counsel William S. Rosenstadt, Esq., Jason Ye, Esq. or Yarona Yieh, Esq. of Ortoli Rosenstadt LLP at wsr@orllp.legal,
jye@orllp.legal or yly@orllp.legal.
Sincerely,
/s/ How Meng Hock
Chief Executive Officer